Park Square has placed Aarif Khakoo, MD, MBA as Chief Scientific Officer at Generate:Biomedicines.
Generate:Biomedicines (“Generate”) today announced the appointment of Aarif Khakoo, MD, MBA, as chief scientific officer. A physician-scientist and experienced biotechnology leader, Dr. Khakoo brings deep expertise in building and scaling platform-driven drug generation engines, with a track record of advancing medicines from discovery through early clinical development. In this role, he will lead scientific and strategic application of The Generate Platform to discover and develop therapeutics across the company’s pipeline.
unknownx500
